Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 10Unknown 6Recruiting 5Not yet recruiting 3Active not recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Myelodysplastic Syndromes 1Motor Activity 1Leukemia, Myeloid, Acute 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Rehabilitation × Clear all
NCT06238596 2025-10-03

ReCaP

Azienda USL Reggio Emilia - IRCCS

Phase NA Active not recruiting
38 enrolled
Genitourinary

Prostatic Neoplasms

NCT03595787 2024-12-18

COHABILIT

Institut Paoli-Calmettes

Phase NA Active not recruiting
50 enrolled
MyeloidOther hematologic neoplasm

Motor Activity, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡